Hemoptysis medical therapy: Difference between revisions
Jump to navigation
Jump to search
| Line 7: | Line 7: | ||
==Medical Therapy== | ==Medical Therapy== | ||
*Hemoptysis is a symptom that indicates an underlying [[Lung|pulmonary]] or extrapulmonary cause. | *Hemoptysis is a symptom that indicates an underlying [[Lung|pulmonary]] or extrapulmonary cause.<ref name="ShigemuraWan2009">{{cite journal|last1=Shigemura|first1=Norihisa|last2=Wan|first2=Innes Y.|last3=Yu|first3=Simon C.H.|last4=Wong|first4=Randolph H.|last5=Hsin|first5=Michael K.Y.|last6=Thung|first6=Hoi K.|last7=Lee|first7=Tak-Wai|last8=Wan|first8=Song|last9=Underwood|first9=Malcolm J.|last10=Yim|first10=Anthony P.C.|title=Multidisciplinary Management of Life-Threatening Massive Hemoptysis: A 10-Year Experience|journal=The Annals of Thoracic Surgery|volume=87|issue=3|year=2009|pages=849–853|issn=00034975|doi=10.1016/j.athoracsur.2008.11.010}}</ref> | ||
*Pharmacologic medical therapy depends on an underlying cause. | *Pharmacologic medical therapy depends on an underlying cause. | ||
*The mainstay of treatment for massive hemoptysis is supportive and surgical therapy. | *The mainstay of treatment for massive hemoptysis is supportive and surgical therapy. | ||
| Line 16: | Line 16: | ||
** Preferred regimen (2): [[drug name]] 500 mg PO q8h for 14-21 days | ** Preferred regimen (2): [[drug name]] 500 mg PO q8h for 14-21 days | ||
** Preferred regimen (3): [[drug name]] 500 mg q12h for 14-21 days | ** Preferred regimen (3): [[drug name]] 500 mg q12h for 14-21 days | ||
** Alternative regimen (1): [[drug name]] 500 mg PO q6h for 7–10 days | ** Alternative regimen (1): [[drug name]] 500 mg PO q6h for 7–10 days | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 19:13, 26 February 2018
|
Hemoptysis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hemoptysis medical therapy On the Web |
|
American Roentgen Ray Society Images of Hemoptysis medical therapy |
|
Risk calculators and risk factors for Hemoptysis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
Hemoptysis is a symptom that indicates an underlying pulmonary or extrapulmonary cause. Pharmacologic medical therapy depends on an underlying cause. However, the mainstay of treatment for massive hemoptysis is supportive and surgical therapy.
Medical Therapy
- Hemoptysis is a symptom that indicates an underlying pulmonary or extrapulmonary cause.[1]
- Pharmacologic medical therapy depends on an underlying cause.
- The mainstay of treatment for massive hemoptysis is supportive and surgical therapy.
Disease Name
- 1 Stage 1 - Massive hemoptysis
References
- ↑ Shigemura, Norihisa; Wan, Innes Y.; Yu, Simon C.H.; Wong, Randolph H.; Hsin, Michael K.Y.; Thung, Hoi K.; Lee, Tak-Wai; Wan, Song; Underwood, Malcolm J.; Yim, Anthony P.C. (2009). "Multidisciplinary Management of Life-Threatening Massive Hemoptysis: A 10-Year Experience". The Annals of Thoracic Surgery. 87 (3): 849–853. doi:10.1016/j.athoracsur.2008.11.010. ISSN 0003-4975.